Navigation Links
The urban evolution lab

Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the University of Antwerp are the first to show that the quantity of amyloid protein in brain cells is a major risk factor for Alzheimer's disease. Amyloid protein has already been known to be the primary component of the senile plaques in the brains of patients. The new discovery demonstrates that the greater the quantity of the protein that is produced, the younger the dementia patient is.

Alzheimer's disease
Alzheimer's disease is a memory disorder that affects up to 70% of all dementia patients. In Belgium, about 100,000 people suffer from this disease. The disease gradually destroys brain cells in the deep areas of the brain that are responsible for memory and knowledge. Ever since the disease was first reported by Alois Alzheimer − 100 years ago now − scientists have been searching diligently for ways to treat it.

Amyloid plaque formation plays a key role
Genetic research has previously shown a direct connection between amyloid protein and the development of senile plaques and loss of cells. Amyloid protein originates when it is cut by enzymes from a larger precursor protein. In very rare cases (fewer than 1 in 1000 patients), mutations appear in that amyloid precursor protein, causing it to change shape and be cut differently. The amyloid protein that is formed now has different characteristics, causing it to begin to stick together and precipitate as amyloid plaques. The development of amyloid plaques in the brain tissue of Alzheimer patients is a central factor in the search for a therapy for Alzheimer's disease.

A lot or not much of the amyloid precursor protein is a risk factor The fact that patients with Down syndrome get Alzheimer's disease shows that the quantity of the amyloid precursor protein contributes to the disease: in fact, patients with Down syndrome have 3 copies of the gene (or hereditary code
'"/>

Source:New Scientist


Page: 1 2

Related biology news :

1. Toxic flood lifts lid on common urban pollution problem
2. Sleep disturbances affect classroom performance
3. Out-of-body experiences may be caused by arousal system disturbances in brain
4. Molecular biology fills gaps in knowledge of bat evolution
5. Same mutation aided evolution in many fish species, Stanford study finds
6. Researchers trace evolution to relatively simple genetic changes
7. Family trees of ancient bacteria reveal evolutionary moves
8. Great White shark evolution debate involves WSU Lake Campus geology professor
9. Revolutionary nanotechnology illuminates brain cells at work
10. The evolutionary triumph of flower power
11. MicroRNAs play a big part in gene regulation - and evolution

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The urban evolution lab

(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, ...(LEID) will be installing its locker system and pa...BACS) at the U.S. Department of Health and Human S... in Bethesda, MD. The locker system will support ...for protecting our nation,s medical research agenc...
(Date:11/5/2009)...New Haven, Conn.Researchers at Yale University hav...ng the body,s immune response to HIV and HIV-infec...eir findings, published online in the Journal of ...l therapeutic approaches for these diseases. , ...e targeting HIV" (ARM-H) and "antibody-recruiting ...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2
... NYU Langone Medical Center scientists and their ... La Jolla, Calif., have discovered an unexpected c...l meningitis, an infection of the central nervous ...nal Nature. The finding may lead to a new way of t... to viral diseases. , The NYU researchers, Michae...
...adly form of malaria for humans, Plasmodium falci...nzees, this group has been fairly isolated on the ...analysis from the Sackler Institute for Comparativ...ry reveals that malarial parasites found in tree-d...ip with P. falciparum and Plasmodium reichenowi...
...tains, from the Apennines to the Alps, have fascin... Walter Alvarez for more than 35 years, resulting ... that traces Italy,s billion-year geologic history...ndbreaking - and often overlooked - discoveries. ,...n & Company, Inc. Alvarez, a UC Berkeley professor...
Other Biology News:Peering inside the skull of a mouse to solve meningitis mystery 2Peering inside the skull of a mouse to solve meningitis mystery 3African thicket rat malaria linked to virulent human form 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 3Italy's geologic history becomes a personal tale in Walter Alvarez's new book 4
(Date:11/5/2009)...ovember 5, 2009 at 4:30 p.m. Eastern Time , B...all/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex...d unaudited financial results for the third quarte...iewed the Company,s highlights for the third quart...ts reflect the operations of OncoGenex Technologie...
(Date:11/5/2009)...ewswire-FirstCall/ -- Wound Management Technologie...ed into a Letter of Intent to purchase all healthc... Inc. (OTC Bulletin Board: VHGI). The deal provide... 4,000,000 shares of WNDM and a royalty agreement ...chnology being acquired from VHGI. WNDM closed a...
(Date:11/5/2009).... 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Co..."Company") today announced,that the Company plans ...,Monday, November 9, 2009, after the market closes...ll at 5:00 pm ET on November 9, 2009,to discuss th...e call by,dialing 1-888-713-4211 or 1-617-213-4864...
(Date:11/4/2009)...ar, which will be presented on November 19 and is ...hemistry processing, will deal with the applicatio...so and micro scale flow chemistry equipment. Prof... recognized with several prestigious prizes and aw... Prize. , Columbia, MD (P...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BMP Sunstone to Report Third Quarter 2009 Financial Results 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...ology To Potentially Improve ...7 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) toda...arch and License Agreement with Genentech, Inc. ex...ional targets for potential improvement,of product...nger,DNA-binding protein nuclease (ZFN) technology...
...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, to...cology chair at the Ecole,Polytechnique Federale d...,in Oncogenesis. Funded through a CHF 2.5 million ...ge the wide scope of ideas and inventions,discover...
...generate antibodies against novel resea...rmany and ST. LOUIS, Feb. 27 ,Sigma-Aldrich(TM) (N...xchange: MOR; Prime Standard Segment, TecDAX) toda...roduce and distribute unique,recombinant research ...D(R),technology. MorphoSys,s AbD Serotec unit will...
Other Biology Technology:Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 2Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 3Debiopharm and EPFL Establish an Oncology Chair 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products: